PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: Primary and Secondary endpoints met in MPS I Trial, page-21

  1. 236 Posts.
    lightbulb Created with Sketch. 29
    yep .. see your point....can't win these days......still 3% will do for now...
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.